{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:52:39Z","timestamp":1787165559007,"version":"build-2736575974"},"reference-count":20,"publisher":"Scientific Scholar","issue":"Suppl 1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background &amp; objectives:<\/jats:title>\n                    <jats:p>\n                      Chronic myeloid leukaemia is (CML) characterized by the presence of a hallmark chromosomal translocation, the Philadelphia chromosome. Although there are many reports available regarding the different variants of\n                      <jats:italic toggle=\"yes\">BCR<\/jats:italic>\n                      -\n                      <jats:italic toggle=\"yes\">ABL<\/jats:italic>\n                      in CML, we studied the co-expression of e13a2 and e14a2 transcripts and a few polymorphisms in CML patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Molecular genetics approach was adapted to screen for polymorphisms, mutation and translocation in\n                      <jats:italic toggle=\"yes\">BCR<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">ABL<\/jats:italic>\n                      kinase domain and\n                      <jats:italic toggle=\"yes\">BCR<\/jats:italic>\n                      -\n                      <jats:italic toggle=\"yes\">ABL<\/jats:italic>\n                      breakpoint region in 73 CML patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      All eight patients with dual transcripts were found to harbour an exonic polymorphism (c.2700 T&gt;C) and an intronic polymorphism (g.109366A&gt;G) that were earlier reported to be associated with co-expression of both the transcripts. We also observed c.763G&gt;A mutation in\n                      <jats:italic toggle=\"yes\">ABL<\/jats:italic>\n                      kinase domain and two polymorphisms, c.2387 A&gt;G and c.2736A&gt;G in the\n                      <jats:italic toggle=\"yes\">BCR<\/jats:italic>\n                      gene.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation &amp; conclusions:<\/jats:title>\n                    <jats:p>\n                      Though our data support the previous findings that co-expression of\n                      <jats:italic toggle=\"yes\">BCR<\/jats:italic>\n                      -\n                      <jats:italic toggle=\"yes\">ABL<\/jats:italic>\n                      transcripts is due to the occurrence of exonic and intronic polymorphisms in the\n                      <jats:italic toggle=\"yes\">BCR<\/jats:italic>\n                      gene, it also shows that the intronic polymorphism can arise without the linked exonic polymorphism. The occurrence of\n                      <jats:italic toggle=\"yes\">ABL<\/jats:italic>\n                      kinase domain mutation is less frequent in Indian population.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/0971-5916.191816","type":"journal-article","created":{"date-parts":[[2016,10,10]],"date-time":"2016-10-10T04:36:33Z","timestamp":1476074193000},"page":"S136-S141","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Dual transcripts of BCR-ABL &amp; different polymorphisms in chronic myeloid leukaemia patients"],"prefix":"10.25259","volume":"143","author":[{"given":"S. Rajashree","family":"Nandagopalan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nivedita","family":"Kuila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sutapa","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh Chandra","family":"Pattnayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyanashyam","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumen","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"R1-18-20241212","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood.V88.7.2375.bloodjournal8872375","article-title":"The diversity of BCR\u2013ABL fusion proteins and their relationship to leukaemia phenotype","volume":"88","author":"Melo","year":"1996","journal-title":"Blood"},{"key":"R2-18-20241212","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/blood.V88.7.2410.bloodjournal8872410","article-title":"Neutrophilic-chronic myeloid leukaemia: a distinct disease with a specific molecular marker (BCR\/ABL with C3\/A2 junction)","volume":"88","author":"Pane","year":"1996","journal-title":"Blood"},{"key":"R3-18-20241212","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukaemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"R4-18-20241212","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0145-2126(01)00197-7","article-title":"Bcr-Abl variants: Biological and clinical aspects","volume":"26","author":"Advani","year":"2002","journal-title":"Leuk Res"},{"key":"R5-18-20241212","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1046\/j.1365-2141.2002.03508.x","article-title":"Dual transcription of b2a2 and b3a2 BCR-ABL transcripts in chronic myeloid leukaemia is confined to patients with a linked polymorphism within the BCR gene","volume":"117","author":"Branford","year":"2002","journal-title":"Br J Haematol"},{"key":"R6-18-20241212","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms","volume":"100","author":"Vardiman","year":"2002","journal-title":"Blood"},{"key":"R7-18-20241212","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1097-2765(00)80336-6","article-title":"SLUG, a ces-1-related zinc finger transcription factor gene with antiapoptotic activity, is a downstream target of the E2A-HLF oncoprotein","volume":"4","author":"Inuki","year":"1999","journal-title":"Mol Cell"},{"key":"R8-18-20241212","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/10428190802714032","article-title":"Presence of a new BCR-ABL kinase domain mutation, C330G in an imatinib naive patient with chronic myeloid leukemia: very low prevalence of BCR-ABL kinase domain mutations in patients with chronic myeloid leukaemia from eastern India","volume":"50","author":"Kuila","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"R9-18-20241212","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/ajh.20682","article-title":"Molecular profiling of chronic myeloid leukaemia in eastern India","volume":"81","author":"Mondal","year":"2006","journal-title":"Am J Hematol"},{"key":"R10-18-20241212","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nm.3161","article-title":"Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells","volume":"19","author":"Robbins","year":"2013","journal-title":"Nat Med"},{"key":"R11-18-20241212","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1136\/jcp.2005.029595","article-title":"e19a2 BCL-ABL fusion transcript in typical chronic myeloid leukaemia: a report of two cases","volume":"59","author":"Mondal","year":"2006","journal-title":"J Clin Pathol"},{"key":"R12-18-20241212","first-page":"553","article-title":"Analysis of Bcr-abl type transcript and its relationship with platelet count in Mexican patients with chronic myeloid leukaemia","volume":"139","author":"Rosas-Cabral","year":"2003","journal-title":"Gac Med Mex"},{"key":"R13-18-20241212","first-page":"605","article-title":"Frequencies of the breakpoint cluster region types of the BCR\/ABL fusion gene in Mexican Mestizo patients with chronic myelogenous leukaemia","volume":"56","author":"Ruiz-Arg\u00fcelles","year":"2004","journal-title":"Rev Invest Clin"},{"key":"R14-18-20241212","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1590\/S1415-47572010005000037","article-title":"Frequencies of BCR-ABL1 fusion transcripts among Sudanese chronic myeloid leukaemia patients","volume":"33","author":"Osman","year":"2010","journal-title":"Genet Mol Biol"},{"key":"R15-18-20241212","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4103\/0971-5916.93423","article-title":"Cytogenetic & molecular analyses in adult chronic myelogenous leukaemia patients in north India","volume":"135","author":"Anand","year":"2012","journal-title":"Indian J Med Res"},{"key":"R16-18-20241212","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.hoc.2011.09.005","article-title":"BCR-ABL mutations in chronic myeloid leukaemia","volume":"25","author":"Ernst","year":"2011","journal-title":"Hematol Oncol Clin North Am"},{"key":"R17-18-20241212","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.biopsych.2005.02.019","article-title":"The breakpoint cluster region gene on chromosome 22q11 is associated with bipolar disorder","volume":"57","author":"Hashimoto","year":"2005","journal-title":"Biol Psychiatry"},{"key":"R18-18-20241212","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/pgmj.73.866.834","article-title":"Bipolar disorder associated with interferon-alpha treatment","volume":"73","author":"Iancu","year":"1997","journal-title":"Postgrad Med J"},{"key":"R19-18-20241212","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature05610","article-title":"Patterns of somatic mutation in human cancer genomes","volume":"446","author":"Greenman","year":"2007","journal-title":"Nature"},{"key":"R20-18-20241212","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4137\/BBI.S5498","article-title":"Candidate single nucleotide polymorphism markers for arsenic responsiveness of protein targets","volume":"4","author":"Isokpehi","year":"2010","journal-title":"Bioinform Biol Insights"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/02223309-201643001-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T18:57:55Z","timestamp":1751482675000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/dual-transcripts-of-bcr-abl-different-polymorphisms-in-chronic-myeloid-leukaemia-patients\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":20,"journal-issue":{"issue":"Suppl 1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.4103\/0971-5916.191816","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}